Lindsay T. Fourman, MD

Massachusetts General Hospital and Harvard Medical School, Boston, Massachusetts, USA
Boston, Massachusetts, United States

Disclosure information not submitted.

Presentation(s):

• SUN-676 - A 12-Month Randomized, Multicenter, Double-Blind, Placebo-Controlled Phase 3 Study to Evaluate the Safety and Efficacy of Metreleptin in Subjects with Partial Lipodystrophy: The METRE-PL Study

  Sunday, June 14, 2026
  9:00 AM - 4:00 PM CT